Correlation Between China Molybdenum and Bristol Myers

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both China Molybdenum and Bristol Myers at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining China Molybdenum and Bristol Myers into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between China Molybdenum Co and Bristol Myers Squibb, you can compare the effects of market volatilities on China Molybdenum and Bristol Myers and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in China Molybdenum with a short position of Bristol Myers. Check out your portfolio center. Please also check ongoing floating volatility patterns of China Molybdenum and Bristol Myers.

Diversification Opportunities for China Molybdenum and Bristol Myers

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between China and Bristol is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding China Molybdenum Co and Bristol-Myers Squibb in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Bristol-Myers Squibb and China Molybdenum is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on China Molybdenum Co are associated (or correlated) with Bristol Myers. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Bristol-Myers Squibb has no effect on the direction of China Molybdenum i.e., China Molybdenum and Bristol Myers go up and down completely randomly.

Pair Corralation between China Molybdenum and Bristol Myers

If you would invest  61.00  in China Molybdenum Co on December 29, 2023 and sell it today you would earn a total of  20.00  from holding China Molybdenum Co or generate 32.79% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy0.0%
ValuesDaily Returns

China Molybdenum Co  vs.  Bristol-Myers Squibb

 Performance 
       Timeline  
China Molybdenum 

Risk-Adjusted Performance

13 of 100

 
Low
 
High
Good
Compared to the overall equity markets, risk-adjusted returns on investments in China Molybdenum Co are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak essential indicators, China Molybdenum reported solid returns over the last few months and may actually be approaching a breakup point.
Bristol-Myers Squibb 

Risk-Adjusted Performance

0 of 100

 
Low
 
High
Very Weak
Over the last 90 days Bristol Myers Squibb has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable primary indicators, Bristol Myers is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

China Molybdenum and Bristol Myers Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with China Molybdenum and Bristol Myers

The main advantage of trading using opposite China Molybdenum and Bristol Myers positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if China Molybdenum position performs unexpectedly, Bristol Myers can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bristol Myers will offset losses from the drop in Bristol Myers' long position.
The idea behind China Molybdenum Co and Bristol Myers Squibb pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges